Cite
HARVARD Citation
Ye, X. et al. (2021). Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial. European journal of endocrinology. 184 (2), pp. 277-287. [Online].